MENU
CSTL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Castle Biosciences (CSTL) Ownership - Who owns Castle Biosciences?
Profile
Industry
N/A
Address
505 South Friendswood Drive
Phone
+1 866 788-9007
Employees
610
Web
https://www.castlebiosciences.com
Details
Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
608.02M
P/E Ratio
N/A
Total Cash
243.1M
Projected Growth
N/A
Total Debt
15.34M
Revenue
219.79M
Risk (Beta)
1.20
Dividend Yield
N/A
Total Cash/Share
8.86
Total Debt/Equity
N/A
Revenue/Share
8.20 USD as % of share price
Fundamentals
CSTL
Capitalization
608M
P/E Ratio
N/A
Risk (Beta)
1.20
Dividend Yield
N/A
Total Cash
243M
Total Cash/Share
8.86
Total Debt
15.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
8.20%
Revenue
220M
ROE
N/A
Book Value
391M
P/B Ratio
1.56
Cash Flow
N/A
Earnings
-2.14
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
27K
Current Ratio
6.20
Current Revenue Per Employee
108393.45
Dividends Per Share - Security
N/A
EBITDA
-45.02M
Float
N/A
Float - Current
N/A
Gross Income Margin
81.21
Revenue To Assets
-12.76
Shares Held By Institutions
712M
Shares Outstanding - Current
27.4M
Total Liabilities
62.1M
Total Volume MTD
N/A
Value
-1
Gain YTD
47.359
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients.
Industry MedicalSpecialties
Profile
Fundamentals
Details
Industry
N/A
Address
505 South Friendswood Drive
Phone
+1 866 788-9007
Employees
610
Web
https://www.castlebiosciences.com